Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Replaces testosterone in men with proven deficiency. | Shrinks an enlarged prostate; slows male hair loss. |
| Body system | Hormones & Bones | Kidney & Bladder |
| Drug class | Androgens | 5-alpha reductase inhibitors |
| Supply | Controlled drugWHO essential medicine | Prescription only |
| Main uses | Male hypogonadism, Delayed puberty, Gender-affirming hormone therapy, Low libido in menopausal women (specialist, low dose) | Enlarged prostate, Male-pattern hair loss |
| How it works | Restores normal male hormone levels. | Blocks the hormone that enlarges the prostate and shrinks hair follicles. |
| Starts working | — | — |
| Half-life | — | 5–6 hours |
| Typical adult dose | Gel: usually 50 mg daily, adjusted to blood levels. Injections every 2–3 weeks or every 10–14 weeks depending on type. | Prostate: 5 mg once a day. Hair loss: 1 mg once a day. |
| Forms | Gel, Injection, Patch, Capsule | Tablet, Topical spray (some countries) |
| Common side effects | Acne, Raised red cell count, Breast tenderness, Mood changes | Reduced libido, Erectile problems, Reduced ejaculate |
| Serious side effects | Thick blood (polycythaemia), Infertility, Blood clots, Prostate enlargement | Depression and suicidal thoughts (reported), Persistent sexual side effects after stopping (reported), Breast lumps |
| Don't take if | — | Women who are or may be pregnant must not handle crushed tablets; Allergy to finasteride |
| Alcohol | — | Usually no problem in moderation. No specific interaction. |
| Pregnancy | Usually avoidedCan masculinise a female fetus — partners should avoid skin contact with gel. | Usually avoidedCan harm a male fetus; women shouldn't handle crushed tablets. |
| Breastfeeding | — | Usually avoidedNot applicable to women; semen exposure during pregnancy is a concern. |
| In use since | 1937 | 1992 |
| Brand names | United States: AndroGel, Testim, Depo-TestosteroneUnited Kingdom: Testogel, Tostran, Nebido, SustanonIndia: Testoviron, Sustanon | United States: Proscar, PropeciaUnited Kingdom: Proscar, PropeciaIndia: Finast, Finpecia |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | G03BA03 | G04CB01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker